指南針(300803.SZ):擬1.61億元收購先鋒基金33.3074%股權
格隆匯3月18日丨指南針(300803.SZ)公佈,公司於2025年3月18日召開的第十三屆董事會第三十八次會議審議通過了《關於收購先鋒基金管理有限公司部分股權的議案》,公司與大連亞聯投資管理有限公司(簡稱“大連亞聯”)簽署了《關於先鋒基金管理有限公司之股權轉讓協議》,公司將收購大連亞聯持有的先鋒基金管理有限公司(簡稱“先鋒基金”或“標的公司”)33.3074%股權,交易價格爲1.6132億元人民幣。
本次交易完成後,公司將持有先鋒基金95.0100%股權,實現對先鋒基金股權的進一步集中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.